Cited by 4,917Antifungal resistance and susceptibilityFungal Infections and StudiesNeutropenia and Cancer Infections

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Open access

De Pauw, Ben, Walsh, Thomas J., Donnelly, J. Peter, Stevens, David A., Edwards, John E., Calandra, Thierry, Pappas, Peter G., Maertens, Johan, Lortholary, Olivier, Kauffman, Carol A., Denning, David W., Patterson, Thomas F., Maschmeyer, Georg, Bille, Jacques, Dismukes, William E., Herbrecht, Raoul, Hope, William W., Kibbler, Christopher C., Kullberg, Bart Jan, Marr, Kieren A., Muñoz, Patricia, Odds, Frank C., Perfect, John R., Restrepo, Angela, Ruhnke, Markus, Segal, Brahm H., Sobel, Jack D., Sorrell, Tania C., Viscoli, Claudio, Wingard, John R., Zaoutis, Theoklis, Bennett, John E.·2008·Clinical Infectious Diseases

DOI 10.1086/588660PMC PMC2671227

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of such studies. METHODS: After the introduction of the original European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group definitions, advances in diagnostic technology and the recognition of areas in need of improvement led to a revision of this document. The revision process started with a meeting of participants in 2003, to decide on the process and to draft the proposal. This was followed by several rounds of consultation until a final draft was approved in 2005. This was made available for 6 months to allow public comment, and then the manuscript was prepared and approved. RESULTS: The revised definitions retain the original classifications of "proven," "probable," and "possible" invasive fungal disease, but the definition of "probable" has been expanded, whereas the scope of the category "possible" has been diminished. The category of proven invasive fungal disease can apply to any patient, regardless of whether the patient is immunocompromised, whereas the probable and possible categories are proposed for immunocompromised patients only. CONCLUSIONS: These revised definitions of invasive fungal disease are intended to advance clinical and epidemiological research and may serve as a useful model for defining other infections in high-risk patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1086/588660

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citation
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,705
Self-citation
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
Aşçıoğlu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Billé, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,315
Self-citation
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., Ullmann, A. J., Walsh, T. J., HELFGOTT, D. C., Hołowiecki, J., Stockelberg, D., Goh, Y. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,802
Self-citation
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P. H., Langston, A. A., Tarantolo, S., Greinix, H., de Azevedo, W. M., Reddy, V. S., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,339
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Self-citation
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszyńska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 907
Self-citation
Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society.
Austin, J. H. M., Müller, N. L., Friedman, P. J., Hansell, D. M., Naidich, D. P., Rémy-Jardin, M., Webb, W. R., & Zerhouni, E. A. (1996) · Radiology · doi:10.1148/radiology.200.2.8685321 · Cited by 836
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine · doi:10.1097/00005792-200007000-00006 · Cited by 791
Self-citation
Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)
Cornely, O. A., Maertens, J. A., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heußel, C. P., Lortholary, O., Rieger, C. T., Boehme, A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514341 · Cited by 744
Self-citation

Flagged first, then by citations

Show all 28 references

Sorted by citations

Items 601–700 of 1,024

A Regulator of Aspergillus fumigatus Extracellular Proteolytic Activity Is Dispensable for Virulence
Bergmann, A., Hartmann, T., Cairns, T. C., Bignell, E., & Krappmann, S. (2009) · Infection and Immunity · doi:10.1128/iai.00425-09 · Cited by 73
Prognostic Factors for Survival in Patients with Acute Invasive Fungal Rhinosinusitis
Cho, H., Jang, M.-S., Hong, S. D., Chung, S., Kim, H. Y., & Dhong, H. (2015) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2015.29.4115 · Cited by 73
A Cohort of 169 Chronic Granulomatous Disease Patients Exposed to BCG Vaccination: a Retrospective Study from a Single Center in Shanghai, China (2004–2017)
Zhou, Q., Hui, X., Ying, W., Hou, J. W., Wang, W., Liu, D., Wang, Y., Yu, Y., Wang, J., Sun, J., et al. (2018) · Journal of Clinical Immunology · doi:10.1007/s10875-018-0486-y · Cited by 74
Molecular Diagnosis of Invasive Aspergillosis and Detection of Azole Resistance by a Newly Commercialized PCR Kit
Dannaoui, É., Gabriel, F., Gaboyard, M., Lagardere, G., Audebert, L., Quesne, G., Godichaud, S., Verweij, P. E., Accoceberry, I., & Bougnoux, M. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01032-17 · Cited by 72
The burden of Invasive Aspergillosis in patients with haematological malignancy: A meta-analysis and systematic review
van de Peppel, R. J., Visser, L. G., Dekkers, O. M., & de Boer, M. G. J. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.02.012 · Cited by 72
Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma
Little, J. S., Aleissa, M. M., Beluch, K., Gonzalez-Bocco, I. H., Marty, F. M., Manne‐Goehler, J., Koo, S., Hammond, S. P., & Jacobson, C. A. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007474 · Cited by 74
Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: An useful tool for diagnosis and assessment of outcome in clinical trials
Caillot, D., Latrabe, V., Thiébaut, A., Herbrecht, R., de Botton, S., Pigneux, A., Monchecourt, F., Mahi, L., Alfandari, S., & Couaillier, J.-F. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.05.058 · Cited by 72
Self-citation
Invasive fungal disease in systemic lupus erythematosus: A systematic review of disease characteristics, risk factors, and prognosis
Wang, L. R., Barber, C. E. H., Johnson, A. S., & Barnabe, C. C. M. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.06.001 · Cited by 72
The Serum Galactomannan Index Predicts Mortality in Hematopoietic Stem Cell Transplant Recipients With Invasive Aspergillosis
Fisher, C. E., Stevens, A. M., Leisenring, W. M., Pergam, S. A., Boeckh, M., & Hohl, T. M. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit393 · Cited by 72
New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies
Patterson, T. F., & Donnelly, J. P. (2019) · Journal of Fungi · doi:10.3390/jof5010009 · Cited by 72
Self-citation
Occurrence, presentation and treatment of candidemia
Mikulska, M., Del Bono, V., Ratto, S., & Viscoli, C. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.52 · Cited by 71
Self-citation
Pharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model
Seyedmousavi, S., Brüggemann, R. J. M., Meis, J. F. G. M., Melchers, W. J. G., Verweij, P. E., & Mouton, J. W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04907-14 · Cited by 71
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching
Oltolini, C., Greco, R., Galli, L., Clerici, D. T., Lorentino, F., Xue, E., Stanghellini, M. T. L., Giglio, F., Uhr, L., Ripa, M., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.01.013 · Cited by 71
Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
Zurl, C., Waller, M., Schwameis, F., Muhr, T., Bauer, N., Zollner‐Schwetz, I., Valentin, T., Meinitzer, A., Ullrich, E., Wunsch, S., et al. (2020) · Journal of Fungi · doi:10.3390/jof6020090 · Cited by 71
Invasive Pulmonary Aspergillosis in Patients with SARS-CoV-2 Infection: A Systematic Review of the Literature
Apostolopoulou, A., Garrigos, Z. E., Vijayvargiya, P., Lerner, A. H., & Farmakiotis, D. (2020) · Diagnostics · doi:10.3390/diagnostics10100807 · Cited by 72
Epidemiology of Candida kefyr in Patients with Hematologic Malignancies
Dufresne, S. F., Marr, K. A., Sydnor, E. R. M., Staab, J. F., Karp, J. E., Lu, K. Y., Zhang, S. X., Lavallée, C., Perl, T. M., & Neofytos, D. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00131-14 · Cited by 71
Self-citation
Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value
Park, S. Y., Lim, C., Lee, S., Choi, S., Kim, Y. S., Woo, J. H., Song, J., Kim, M. Y., Chae, E. J., Do, K., et al. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.08.007 · Cited by 71
Reactivity of (1 → 3)-β-d-glucan assay in bacterial bloodstream infections
Albert, O., Toubas, D., Strady, C., Cousson, J., Delmas, C., Vernet, V., & Villena, I. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1244-8 · Cited by 71
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project
Pagano, L., Caira, M., Nosari, A., Cattaneo, C., Fanci, R., Bonini, A., Vianelli, N., Garzia, M., Mancinelli, M., Tosti, M. E., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.042598 · Cited by 72
Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study
León, C., Álvarez-Lerma, F., Ruiz‐Santana, S., de Leon, M. A. M., Nolla‐Salas, J., Jordà, R., Saavedra, P., Palomar, M., & The EPCAN Study Group (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0618-z · Cited by 72
Invasive infections caused by Saprochaete capitata in patients with haematological malignancies: Report of five cases and review of the antifungal therapy
García‐Ruiz, J. C., López-Soria, L., Olazábal, I., Amutio, E., Arrieta-Aguirre, I., Benito, V. V., Pontón, J., & Moragues, M. D. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.02.004 · Cited by 71
The Role of Bronchoalveolar Lavage Galactomannan in the Diagnosis of Pediatric Invasive Aspergillosis
Desai, R., Ross, L. A., & Hoffman, J. A. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818f0934 · Cited by 71
Penicilliosis in Children Without HIV Infection—Are They Immunodeficient?
Lee, P. P. W., Chan, K. W., Lee, T.-L., Ho, M., Chen, X., Li, C.-H., Chu, K.-M., Zeng, H., & Lau, Y. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir754 · Cited by 71
Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients
Hoenigl, M., Koidl, C., Duettmann, W., Seeber, K., Wagner, J., Buzina, W., Wölfler, A., Raggam, R. B., Thornton, C. R., & Krause, R. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.10.003 · Cited by 71
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients
Montagna, M. T., Lovero, G., Coretti, C., Martinelli, D., Delia, M., De Giglio, O., Caira, M., Puntillo, F., D’Antonio, D., Venditti, M., et al. (2014) · Infection · doi:10.1007/s15010-013-0539-3 · Cited by 70
Self-citation
Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis
Springer, J., Lackner, M., Nachbaur, D., Girschikofsky, M., Risslegger, B., Mutschlechner, W., Fritz, J., Heinz, W., Einsele, H., Ullmann, A. J., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.009 · Cited by 70
Risk Factors for Mortality in Patients with Invasive Mucormycosis
Hong, H., Lee, Y., Kim, T., Lee, J., Chung, Y., Kim, M., Kim, S., Choi, S., Kim, Y. S., Woo, J. H., et al. (2013) · Infection and Chemotherapy · doi:10.3947/ic.2013.45.3.292 · Cited by 70
Clinical evaluation of the newly formatted lateral‐flow device for invasive pulmonary aspergillosis
Hoenigl, M., Eigl, S., Heldt, S., Duettmann, W., Thornton, C. R., & Prattes, J. (2017) · Mycoses · doi:10.1111/myc.12704 · Cited by 70
Coccidioidomycosis Complement Fixation Titer Trends in the Age of Antifungals
McHardy, I. H., Dinh, B.-T., Waldman, S., Stewart, E., Bays, D. J., Pappagianis, D., & Thompson, G. R. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01318-18 · Cited by 71
Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis
Varon, A. G., Nouér, S. A., Barreiros, G., Trope, B. M., Magalhães, F., Akiti, T., Garnica, M., & Nucci, M. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.08.011 · Cited by 71
Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies
Hoenigl, M., Raggam, R. B., Salzer, H. J. F., Valentin, T., Valentin, A., Zollner‐Schwetz, I., Strohmeier, A. T., Seeber, K., Wölfler, A., Sill, H., et al. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.02.002 · Cited by 70
Evaluation of species distribution and risk factors of candidemia: A multicenter case-control study
Yapar, N., Pullukçu, H., Avkan-Oğuz, V., Kutlu, S. S., Ertuğrul, B., Saçar, S., Cetin, B., & Kaya, O. (2010) · Medical Mycology · doi:10.3109/13693786.2010.501344 · Cited by 70
Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high‐risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin‐amphotericin combination therapies
Abidi, M. Z., Sohail, M. R., Cummins, N. W., Wilhelm, M. P., Wengenack, N. L., Brumble, L. M., Shah, H., Hata, D. J., McCullough, A. E., Wendel, A. J., et al. (2014) · Mycoses · doi:10.1111/myc.12222 · Cited by 70
Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children
King, J., Pana, Z. D., Lehrnbecher, T., Steinbach, W. J., & Warris, A. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix053 · Cited by 70
18F-FDG PET/CT for invasive fungal infection in immunocompromised patients
Leroy‐Freschini, B., Treglia, G., Argemi, X., Bund, C., Kessler, R., Herbrecht, R., & Impériale, A. (2018) · QJM · doi:10.1093/qjmed/hcy128 · Cited by 70
Self-citation
Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Blood Isolates
Arastehfar, A. A., Daneshnia, F., Najafzadeh, M. J., Hagen, F., Mahmoudi, S., Salehi, M., Zarrinfar, H., Namvar, Z., Zareshahrabadi, Z., Khodavaisy, S., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00206 · Cited by 70
Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain
Escribano, P., Rodríguez‐Sánchez, B., Díaz-García, J., Martín-Gómez, M. T., Ibáñez-Martínez, E., Rodríguez–Mayo, M., Peláez, T., de la Pedrosa, E. G. G., Tejero-García, R., Marimón, J. M., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.09.042 · Cited by 72
Evaluation of 28 cases of mucormycosis
Kurşun, E., Turunç, T., Demıroğlu, Y. Z., Alışkan, H. E., & Arslan, A. H. (2015) · Mycoses · doi:10.1111/myc.12278 · Cited by 69
Clinical Features and Outcome of Mucormycosis
Camara-Lemarroy, C. R., González-Moreno, E. I., Rodríguez‐Gutiérrez, R., Rendón-Ramírez, E. J., Ayala-Cortés, A. S., Fraga-Hernández, M. L., García-Labastida, L. E., & Galarza-Delgado, D. Á. (2014) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2014/562610 · Cited by 69
Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status
Heldt, S., & Hoenigl, M. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0275-8 · Cited by 69
Evaluation of a Novel Global Immunity Assay to Predict Infection in Organ Transplant Recipients
Mian, M., Natori, Y., Ferreira, V. H., Selzner, N., Husain, S., Singer, L. G., Kim, S. J., Humar, A., & Kumar, D. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1008 · Cited by 69
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study
Bergin, S. P., Chemaly, R. F., Dadwal, S., Hill, J. A., Lee, Y. J., Haidar, G., Luk, A., Drelick, A. C., Chin-Hong, P. V., Benamu, E., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad599 · Cited by 69
Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis
Yeh, T., Liu, H., Hou, J., Chen, K., Huang, T., Chang, C., & Liang, D. (2014) · Cancer · doi:10.1002/cncr.28524 · Cited by 69
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies
Cumpston, A., Caddell, R. J., Shillingburg, A., Lu, X., Wen, S., Hamadani, M., Craig, M., & Kanate, A. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00581-15 · Cited by 69
The impact of invasive fungal diseases on survival after lung transplantation
Arthurs, S. K., Eid, A. J., Deziel, P. J., Marshall, W. F., Cassivi, S. D., Walker, R. C., & Razonable, R. R. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2009.01076.x · Cited by 69
Comparison of a novel Aspergillus lateral-flow device and the Platelia® galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation
Held, J., Schmidt, T., Thornton, C. R., Kotter, E., & Bertz, H. (2013) · Infection · doi:10.1007/s15010-013-0472-5 · Cited by 69
Utility of PCR in Diagnosis of Invasive Fungal Infections: Real-Life Data from a Multicenter Study
Lass‐Flörl, C., Mutschlechner, W., Aigner, M., Grif, K., Marth, C., Girschikofsky, M., Grander, W., Greil, R., Russ, G., Cerkl, P., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02965-12 · Cited by 69
Impact of Hypoalbuminemia on Voriconazole Pharmacokinetics in Critically Ill Adult Patients
Vanstraelen, K., Wauters, J., Vercammen, I., de Loor, H., Maertens, J. A., Lagrou, K., Annaert, P., & Spriet, I. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03641-14 · Cited by 69
Self-citation
Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis
Burghi, G., Lemiale, V., Seguin, A., Lambert, J., Lacroix, C., Canet, E., Moreau, A., Ribaud, P., Schnell, D., Mariotte, É., et al. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2344-8 · Cited by 69
Antifungal prophylaxis in pediatric hematology/oncology: New choices & new data
Dvorak, C. C., Fisher, B. T., Sung, L., Steinbach, W. J., Nieder, M. L., Alexander, S. W., & Zaoutis, T. E. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23415 · Cited by 69
Self-citation
Antimicrobial effect of chitosan–silver–copper nanocomposite on Candida albicans
Ashrafi, M., Bayat, M., Mortazavi, P., Hashemi, S. J., & Meimandipour, A. (2020) · Journal of nanostructure in chemistry · doi:10.1007/s40097-020-00331-3 · Cited by 69
Histoplasmosis: Epidemiology, Diagnosis, and Clinical Manifestations
Linder, K. A., & Kauffman, C. A. (2019) · Current Fungal Infection Reports · doi:10.1007/s12281-019-00341-x · Cited by 68
Self-citation
Aspergillosis, Avian Species and the One Health Perspective: The Possible Importance of Birds in Azole Resistance
Melo, A. M., Stevens, D. A., Tell, L. A., Veríssimo, C., Sabino, R., & Xavier, M. O. (2020) · Microorganisms · doi:10.3390/microorganisms8122037 · Cited by 68
Self-citation
Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: a systematic review and meta-analysis
Panackal, A. A., Parisini, E., & Proschan, M. A. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.07.007 · Cited by 68
Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis
Park, S. Y., Lee, S., Choi, S., Sung, H., Kim, M., Choi, C., Hong, S., Oh, Y., Shim, T. S., Koh, Y., et al. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.08.014 · Cited by 68
Variability of Voriconazole Plasma Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Cytochrome P450 Polymorphisms and Comedications on Initial and Subsequent Trough Levels
Gautier‐Veyret, E., Fonrose, X., Tonini, J., Thiébaut, A., Bartoli, M., Quésada, J.-L., Bulabois, C., Cahn, J.-Y. Y., & Stanke‐Labesque, F. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04838-14 · Cited by 68
Influence of Polymorphisms in Innate Immunity Genes on Susceptibility to Invasive Aspergillosis after Stem Cell Transplantation
de Boer, M. G. J., Jolink, H., Halkes, C. J. M., van der Heiden, P. L. J., Kremer, D., Falkenburg, J. H. F., van de Vosse, E., & van Dissel, J. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018403 · Cited by 68
Detection of (1, 3)-β-d-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts
Theel, E. S., Jespersen, D. J., Iqbal, S., Bestrom, J. E., Rollins, L. O., Misner, L., Markley, B., Mandrekar, J. N., Baddour, L. M., LIMPER, A. H., et al. (2012) · Mycopathologia · doi:10.1007/s11046-012-9579-y · Cited by 68
InvasiveScopulariopsis brevicaulisinfection in an immunocompromised patient and review of prior cases caused byScopulariopsisandMicroascusspecies
Iwen, P. C., Schutte, S. D., Florescu, D. F., Noel, R. K., & Sigler, L. (2012) · Medical Mycology · doi:10.3109/13693786.2012.675629 · Cited by 68
Invasive Fungal Sinusitis of the Sphenoid Sinus
Lee, D. H., Yoon, T. M., Lee, J. K., Joo, Y., Park, K. H., & Lim, S. C. (2014) · Clinical and Experimental Otorhinolaryngology · doi:10.3342/ceo.2014.7.3.181 · Cited by 68
Outbreak of Invasive Wound Mucormycosis in a Burn Unit Due to Multiple Strains of Mucor circinelloides f. circinelloides Resolved by Whole-Genome Sequencing
Garcia‐Hermoso, D., Criscuolo, A., Lee, S. C., Legrand, M. M., Chaouat, M., Denis, B., Lafaurie, M., Rouveau, M., Soler, C., Schaal, J.-V., et al. (2018) · mBio · doi:10.1128/mbio.00573-18 · Cited by 68
Histoplasmosis and Tuberculosis Co-Occurrence in People with Advanced HIV
Caceres, D. H., & Valdes, A. (2019) · Journal of Fungi · doi:10.3390/jof5030073 · Cited by 68
Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections
Lamoth, F., Lewis, R. E., & Kontoyiannis, D. P. (2020) · Journal of Fungi · doi:10.3390/jof7010017 · Cited by 68
Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples
Reinwald, M., Spiess, B., Heinz, W. J., Vehreschild, J. J., Lass‐Flörl, C., Kiehl, M., Schultheis, B., Krause, S. W., Wolf, H., Bertz, H., et al. (2012) · European Journal of Haematology · doi:10.1111/j.1600-0609.2012.01806.x · Cited by 67
Self-citation
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999–2015
Heo, S. T., Tatara, A. M., Jiménez-Ortigosa, C., Jiang, Y., Lewis, R. E., Tarrand, J., Tverdek, F., Albert, N. D., Verweij, P. E., Meis, J. F., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix297 · Cited by 67
Incidence and Outcome of Invasive Fungal Diseases in Children With Hematological Malignancies and/or Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Study
Lehrnbecher, T., Schöning, S., Poyer, F., Georg, J., Becker, A., Gordon, K., Attarbaschi, A., & Groll, A. H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00681 · Cited by 67
Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies
Pardo, E., Lemiale, V., Mokart, D., Stoclin, A., Moreau, A., Kerhuel, L., Calvet, L., Valade, S., JONG, A. D., Darmon, M., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05789-6 · Cited by 67
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer
Maertens, J. A., Lodewyck, T., Donnelly, J. P., Chantepie, S., Robin, C., Blijlevens, N. M. A., Turlure, P., Selleslag, D., Baron, F., Aoun, M., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac623 · Cited by 67
Self-citation
Core outcomes and definitions for pediatric fever and neutropenia research: A consensus statement from an international panel
Haeusler, G. M., Phillips, R. S., Lehrnbecher, T., Thursky, K., Sung, L., & Ammann, R. A. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25335 · Cited by 67
Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina.
Córdoba, S. B., Vivot, W., Bosco‐Borgeat, M. E., Taverna, C. G., Szusz, W., Murisengo, O. A., Isla, G., & Davel, G. (2011) · PubMed · doi:10.1590/s0325-75412011000300003 · Cited by 68
Invasive candidiasis: A review of nonculture-based laboratory diagnostic methods
Ahmad, S., & Khan, Z. U. (2012) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.99482 · Cited by 67
How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation
Wingard, J. R., Hiemenz, J. W., & Jantz, M. A. (2012) · Blood · doi:10.1182/blood-2012-02-378976 · Cited by 67
Self-citation
Breakthrough invasive mould infections in patients treated with caspofungin
Pang, K.-A. P., Godet, C., Fekkar, A., Scholler, J., Nivoix, Y., Letscher‐Bru, V., Massias, L., Kauffmann‐Lacroix, C., Elsendoorn, A., Uzunov, M., et al. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.12.015 · Cited by 67
Self-citation
Fungal infections in intensive care unit: Challenges in diagnosis and management
Bajwa, S., & Kulshrestha, A. (2013) · Annals of Medical and Health Sciences Research · doi:10.4103/2141-9248.113669 · Cited by 67
Epidemiology of invasive fungal infections in lung transplant recipients on long‐term azole antifungal prophylaxis
Chong, P. P., Kennedy, C. C., Hathcock, M. A., Kremers, W. K., & Razonable, R. R. (2015) · Clinical Transplantation · doi:10.1111/ctr.12516 · Cited by 67
Combat-Related Invasive Fungal Wound Infections
Tribble, D. R., & Rodríguez, C. J. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0205-y · Cited by 67
Epidemiology, clinical manifestations, and outcomes of S cedosporium infections among solid organ transplant recipients
Johnson, L. S., Shields, R. K., & Clancy, C. J. (2014) · Transplant Infectious Disease · doi:10.1111/tid.12244 · Cited by 67
Diagnosing invasive fungal disease in critically ill patients
Hsu, J. L., Ruoss, S. J., Bower, N. D., Lin, M., Holodniy, M., & Stevens, D. A. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.581223 · Cited by 69
Self-citation
Invasive Fungal Infections in Patients with Hematologic Malignancies (Aurora Project): Lights and Shadows During 18-Months Surveillance
Montagna, M. T., Giglio, O. D., Napoli, C., Lovero, G., Caggiano, G., Delia, M., Pastore, D., Santoro, N., & Specchia, G. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13010774 · Cited by 67
Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern
Taj‐Aldeen, S. J., Kolecka, A., Boesten, R., Alolaqi, A., AlMaslamani, M. A. R. S., Chandra, P., Meis, J. F. G. M., & Boekhout, T. (2013) · Infection · doi:10.1007/s15010-013-0570-4 · Cited by 67
Azole‐resistant Aspergillus fumigatus isolates carrying TR 34/L98H mutations in Taiwan
Wu, C., Wang, H., Lee, J., Lo, H., Dai, C.-T., Chou, P., Ko, W., & Chen, Y. (2015) · Mycoses · doi:10.1111/myc.12354 · Cited by 67
Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience
Girmenia, C., Frustaci, A. M., Gentile, G., Minotti, C., Cartoni, C., Capria, S., Trisolini, S. M., Matturro, A., Loglisci, G., Latagliata, R., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.053058 · Cited by 67
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review
Bassetti, M., Peghin, M., & Vena, A. (2017) · Infectious Diseases and Therapy · doi:10.1007/s40121-017-0183-9 · Cited by 67
FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging
Douglas, A. P., Thursky, K., Worth, L. J., Drummond, E. G. P., Hogg, A., Hicks, R. J., & Slavin, M. A. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4062-8 · Cited by 67
Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial
Santolaya, M. E., Alvarez, A., Acuña, M., Avilés, C. L., Salgado, C., Tordecilla, J., Varas, M., Venegas, M., Milena Villarroel, C., Marcela Zubieta, A., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky244 · Cited by 67
Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus
Doni, A., Parente, R., Laface, I., Magrini, E. I., Cunha, C., Colombo, F., de Lacerda, J. F., Campos, A., Mapelli, S. N., Petroni, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24021-y · Cited by 68
Self-citation
Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta‐analysis
Shi, C., Shan, Q., Xia, J., Wang, L., Wang, L., Qiu, L., Xie, Y., Lin, N., & Wang, L. (2021) · Mycoses · doi:10.1111/myc.13410 · Cited by 66
Diagnostic Performance of an Aspergillus-Specific Nested PCR Assay in Cerebrospinal Fluid Samples of Immunocompromised Patients for Detection of Central Nervous System Aspergillosis
Reinwald, M., Buchheidt, D., Hummel, M., Dürken, M., Bertz, H., Schwerdtfeger, R., Reuter, S., Kiehl, M. G., Miranda, M. B., Hofmann, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056706 · Cited by 66
Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real‐life study
Falci, D. R., da Rosa, F. B., & Pasqualotto, A. C. (2015) · Mycoses · doi:10.1111/myc.12283 · Cited by 66
Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review
Sun, H., & Singh, N. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.09.020 · Cited by 66
Detection of Urinary Excreted Fungal Galactomannan-like Antigens for Diagnosis of Invasive Aspergillosis
Dufresne, S. F., Datta, K., Li, X., Dadachova, E., Staab, J. F., Patterson, T. F., Feldmesser, M., & Marr, K. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042736 · Cited by 66
Self-citation
Invasive aspergillosis among heart transplant recipients: A 24-year perspective
Muñóz, P., Cerón, I., Valerio, M., Palomo, J., Villa, A., Eworo, A., Fernàndez-Yáñez, J., Guinea, J., & Bouza, E. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.11.003 · Cited by 66
Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience
Stempel, J. M., Hammond, S. P., Sutton, D. A., Weiser, L. M., & Marty, F. M. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv099 · Cited by 66
Early Proinflammatory Cytokines and C‐Reactive Protein Trends as Predictors of Outcome in Invasive Aspergillosis
Chai, L. Y. A., Netea, M. G., Teerenstra, S., Earnest, A., Vonk, A. G., Schlamm, H. T., Herbrecht, R., Troke, P. F., & Kullberg, B. J. (2010) · The Journal of Infectious Diseases · doi:10.1086/656527 · Cited by 68
Self-citation
The T788G Mutation in the cyp51C Gene Confers Voriconazole Resistance in Aspergillus flavus Causing Aspergillosis
Liu, W. Y., Sun, Y., Chen, W., Liu, W., Wan, Z., Bu, D., & Li, R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05477-11 · Cited by 66
Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases
Angebault, C., Lanternier, F., Dalle, F., Schrimpf, C., Roupie, A.-L., Dupuis, A., Agathine, A., Scemla, A., Paubelle, É., Caillot, D., et al. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw128 · Cited by 66
Self-citation
Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome
Feng, J., & Sun, X. (2018) · Infection · doi:10.1007/s15010-018-1149-x · Cited by 66
Epidemiology of invasive fungal infections in immunocompromised children; an Australian national 10‐year review
Bartlett, A. W., Cann, M. P., Yeoh, D. K., Bernard, A., Ryan, A. L., Blyth, C. C., Kotecha, R. S., McMullan, B. J., Moore, A. S., Haeusler, G. M., et al. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27564 · Cited by 66
Acute histoplasmosis in immunocompetent travelers: a systematic review of literature
Staffolani, S., Buonfrate, D., Angheben, A., Gobbi, F. G., Giorli, G., Guerriero, M., Bisoffi, Z., & Barchiesi, F. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3476-z · Cited by 66
Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia
Rausch, C. R., Dinardo, C. D., Maiti, A., Jammal, N., Kadia, T. M., Marx, K. R., Borthakur, G. M., Savoy, J. M., Pemmaraju, N., DiPippo, A. J., et al. (2021) · Cancer · doi:10.1002/cncr.33508 · Cited by 66

Authors: De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., Denning, D. W., Patterson, T. F., Maschmeyer, G., Bille, J., Dismukes, W. E., Herbrecht, R., Hope, W. W., Kibbler, C. C., Kullberg, B. J., Marr, K. A., Muñoz, P., Odds, F. C., Perfect, J. R., Restrepo, A., Ruhnke, M., Segal, B. H., Sobel, J. D., Sorrell, T. C., Viscoli, C., Wingard, J. R., Zaoutis, T., & Bennett, J. E.
Affiliations: Radboud University Medical Center (NL)
Corresponding author: Donnelly, J. Peter
ORCID: Walsh, Thomas J.
Donnelly, J. Peter
Stevens, David A.
Edwards, John E.
Calandra, Thierry
Pappas, Peter G.
Maertens, Johan
Lortholary, Olivier
Denning, David W.
Patterson, Thomas F.
Maschmeyer, Georg
Herbrecht, Raoul
Hope, William W.
Kullberg, Bart Jan
Marr, Kieren A.
Perfect, John R.
Ruhnke, Markus
Segal, Brahm H.
Sobel, Jack D.
Sorrell, Tania C.
Wingard, John R.
Zaoutis, Theoklis
Bennett, John E.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2008-06-15
Volume: 46
Issue: 12
Pages: 1813-1821
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1086/588660
PMC: PMC2671227
OpenAlex: W2166734004
Cited by: 4,917
References: 28
Citations by year: 2026: 85 · 2025: 146 · 2024: 169 · 2023: 172 · 2022: 203 · 2021: 280 · 2020: 362 · 2019: 424 · 2018: 383 · 2017: 354 · 2016: 345 · 2015: 376 · 2014: 363 · 2013: 299 · 2012: 279
FWCI: 140.34
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Clinical Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Institutional Repository University of Antioquia (University of Antioquia) (publishedVersion, cc-by-nc-nd)
PubMed Central (acceptedVersion)
IRIS (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
Research Explorer (The University of Manchester) (submittedVersion)
Radboud Repository (Radboud University) (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion, other-oa)
Radboud Repository (Radboud University) (submittedVersion, other-oa)
Funders: Amgen
Pfizer
GlaxoSmithKline
Sanofi
Gilead Sciences
Children's Hospital of Philadelphia
Wayne State University
University of Pennsylvania
Wellcome Trust
Valeant Pharmaceuticals International
European Commission
University of Aberdeen
European Organisation for Research and Treatment of Cancer
Astellas Pharma
Centre Hospitalier Universitaire Vaudois
Basilea Pharmaceutica
Italfarmaco
National Institutes of Health
University at Buffalo
Medical School, University of Michigan
University of Texas Health Science Center at San Antonio
Medical Research Council
National Health and Medical Research Council
National Institute of Allergy and Infectious Diseases (Z01AI000654)
Janssen Pharmaceuticals
UCB Pharma
Daiichi Sankyo Europe
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
Keywords: invasive fungal infections, diagnostic definitions, immunocompromised patients, clinical trial endpoints, fungal epidemiology
MeSH terms: Humans, Mycoses, Terminology as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks